PMC:7600245 / 21790-22263
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T97 | 436-439 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T78 | 1-9 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T79 | 12-21 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T80 | 154-162 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T201 | 44-45 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T202 | 300-301 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T203 | 350-351 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T204 | 377-385 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
| T205 | 440-447 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | viruses |
| T206 | 469-470 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T296 | 224-229 | Chemical | denotes | T-705 | http://purl.obolibrary.org/obo/CHEBI_134722 |
| T297 | 280-285 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T298 | 302-310 | Chemical | denotes | pyrazine | http://purl.obolibrary.org/obo/CHEBI_30953 |
| T299 | 311-322 | Chemical | denotes | carboxamide | http://purl.obolibrary.org/obo/CHEBI_23004|http://purl.obolibrary.org/obo/CHEBI_37622 |
| T301 | 367-376 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T160 | 198-202 | Sentence | denotes | 2.6. |
| T161 | 203-230 | Sentence | denotes | Favipiravir (Avigan, T-705) |
| T162 | 231-293 | Sentence | denotes | Favipiravir was originally developed by Fujifilm group, Japan. |
| T163 | 294-386 | Sentence | denotes | It is a pyrazine-carboxamide derivative (Figure 4) with a broad-spectrum antiviral activity. |
| T164 | 387-453 | Sentence | denotes | It selectively and potently inhibits the RdRp of RNA viruses [69]. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 564 | 163-171 | Species | denotes | patients | Tax:9606 |
| 584 | 1-21 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 |
| 585 | 154-162 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 597 | 428-432 | Gene | denotes | RdRp | Gene:43740578 |
| 599 | 231-242 | Chemical | denotes | Favipiravir | MESH:C462182 |
| 600 | 302-322 | Chemical | denotes | pyrazine-carboxamide | MESH:D011718 |
| 601 | 454-465 | Chemical | denotes | Favipiravir | MESH:C462182 |